{"title":"红参非皂苷部位通过维持免疫稳态预防老年C57BL/6J小鼠肌少症","authors":"Boo-Yong Lee, Hyun-ji Oh, Heegu Jin","doi":"10.11159/icbb22.001","DOIUrl":null,"url":null,"abstract":"Background The non-saponin fraction (NSF) of Korean red ginseng is a powder in which saponin is eliminated from red ginseng concentrate by fractionation. In this study, we investigated the effect of NSF on age-associated sarcopenia in old C57BL/6J mice. Young (3–6-month-old) and old (20–24-month-old) C57BL/6J mice were orally administered NSF (50 or 200 mg/kg/day) every day for 6 weeks. Throughout the oral treatment period, body weight and grip strength were assessed once a week. After sacrifice, hindlimb muscles were cut out and used for western blotting and hematoxylin and eosin staining to examine the impacts of NSF on sarcopenia and inflammation/oxidative stress. Flow cytometry analysis was conducted to investigate the effect of NSF on immune homeostasis. Blood samples were collected, and the serum levels of insulin-like growth factor 1, pro-inflammatory cytokines, and glutathione were measured. NSF significantly increased muscle strength, mass, and fiber size in old mice. NSF recovered age-associated disturbance of immune homeostasis by retaining CD11b+F4/80+ macrophages and regulating inflammatory biomarkers. NSF also inhibited the age-induced expression of oxidative stress factors. Thus, NSF diminished conventional low-grade chronic inflammatory/oxidative factors, which are the major source of sarcopenia. effects in aged C57BL/6J mice. NSF is a promising restorative agent that could be used to improve sarcopenia in the elderly.","PeriodicalId":394576,"journal":{"name":"Proceedings of the 8th World Congress on New Technologies","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Non-Saponin Fraction Of Korean Red Ginseng Prevents Sarcopenia By Maintaining Immune Homeostasis In Old C57BL/6J Mice\",\"authors\":\"Boo-Yong Lee, Hyun-ji Oh, Heegu Jin\",\"doi\":\"10.11159/icbb22.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background The non-saponin fraction (NSF) of Korean red ginseng is a powder in which saponin is eliminated from red ginseng concentrate by fractionation. In this study, we investigated the effect of NSF on age-associated sarcopenia in old C57BL/6J mice. Young (3–6-month-old) and old (20–24-month-old) C57BL/6J mice were orally administered NSF (50 or 200 mg/kg/day) every day for 6 weeks. Throughout the oral treatment period, body weight and grip strength were assessed once a week. After sacrifice, hindlimb muscles were cut out and used for western blotting and hematoxylin and eosin staining to examine the impacts of NSF on sarcopenia and inflammation/oxidative stress. Flow cytometry analysis was conducted to investigate the effect of NSF on immune homeostasis. Blood samples were collected, and the serum levels of insulin-like growth factor 1, pro-inflammatory cytokines, and glutathione were measured. NSF significantly increased muscle strength, mass, and fiber size in old mice. NSF recovered age-associated disturbance of immune homeostasis by retaining CD11b+F4/80+ macrophages and regulating inflammatory biomarkers. NSF also inhibited the age-induced expression of oxidative stress factors. Thus, NSF diminished conventional low-grade chronic inflammatory/oxidative factors, which are the major source of sarcopenia. effects in aged C57BL/6J mice. NSF is a promising restorative agent that could be used to improve sarcopenia in the elderly.\",\"PeriodicalId\":394576,\"journal\":{\"name\":\"Proceedings of the 8th World Congress on New Technologies\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the 8th World Congress on New Technologies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11159/icbb22.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 8th World Congress on New Technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11159/icbb22.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Non-Saponin Fraction Of Korean Red Ginseng Prevents Sarcopenia By Maintaining Immune Homeostasis In Old C57BL/6J Mice
Background The non-saponin fraction (NSF) of Korean red ginseng is a powder in which saponin is eliminated from red ginseng concentrate by fractionation. In this study, we investigated the effect of NSF on age-associated sarcopenia in old C57BL/6J mice. Young (3–6-month-old) and old (20–24-month-old) C57BL/6J mice were orally administered NSF (50 or 200 mg/kg/day) every day for 6 weeks. Throughout the oral treatment period, body weight and grip strength were assessed once a week. After sacrifice, hindlimb muscles were cut out and used for western blotting and hematoxylin and eosin staining to examine the impacts of NSF on sarcopenia and inflammation/oxidative stress. Flow cytometry analysis was conducted to investigate the effect of NSF on immune homeostasis. Blood samples were collected, and the serum levels of insulin-like growth factor 1, pro-inflammatory cytokines, and glutathione were measured. NSF significantly increased muscle strength, mass, and fiber size in old mice. NSF recovered age-associated disturbance of immune homeostasis by retaining CD11b+F4/80+ macrophages and regulating inflammatory biomarkers. NSF also inhibited the age-induced expression of oxidative stress factors. Thus, NSF diminished conventional low-grade chronic inflammatory/oxidative factors, which are the major source of sarcopenia. effects in aged C57BL/6J mice. NSF is a promising restorative agent that could be used to improve sarcopenia in the elderly.